ROME, N.Y. (AP) — Envisioning a day when millions of drones will buzz around delivering packages, watching crops or inspecting pipelines, a coalition is creating an airspace corridor in upstate New York where traffic management systems will be developed and unmanned aircraft can undergo safety and performance testing.The unmanned aircraft traffic management corridor, jump-started by a $30 million state investment, will extend 50 miles (80 kilometers) west over mostly rural farmland from Griffiss International Airport, a former Air Force base in Rome that is already home to NASA-affiliated drone testing.It will be equipped with radar and ground-based sensors to enable what Democratic Gov.
NYS Entity Status
NYS Filing Date
APRIL 10, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED PARTNERSHIP
2014 - LAGODA INVESTMENT MANAGEMENT, L.P.
Around the Web
- New York advances drone industry with testing corridor
By MARY ESCH, Associated Press - Sunday Oct 22, 2017
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Why Nelson Peltz Wants P.&G. to See Him as a ‘Constructivist’
By ANDREW ROSS SORKIN - Tuesday Jul 18, 2017
The financier, who dislikes the term “activist,” has made his name by investing in companies using a friendlier approach. But he’s still an activist.
- George Soros’ investment firm sheds employees
By Kevin Dugan - Thursday Oct 26, 2017
Nine people, including two portfolio managers, left George Soros’ massive $26 billion investment office this week, The Post has learned. One manager exited to start his own fund with money seeded from Soros, sources told The Post. The other left after posting lackluster returns, the sources said. Seven others, said to be back-office workers, were...
- Martin Shkreli is found guilty of fraud
By Stephanie Clifford and Colin Moynihan - Friday Aug 4, 2017
NEW YORK — Martin Shkreli, accused of defrauding his hedge fund investors and a pharmaceutical company, was convicted on three of eight counts on Friday, after a five-week trial in U.S. District Court in Brooklyn, N.Y.Shkreli was accused of securities and wire fraud related to two hedge funds he ran, MSMB Capital and MSMB Healthcare.The prosecution brought forth an “avalanche” of evidence, as prosecutor Jacquelyn Kasulis put it in her rebuttal argument, that included a threatening letter he sent to the wife of a former employee, statements he sent to MSMB investors showing great returns at the same time he had no money in fund accounts, three versions of a backdated agreement to make it look as if MSMB Capital had invested in Retrophin when it had not, as well as claims about assets under management that were wildly out of line with his actual fund size.